results of trial of ribociclib with everolimus and exemestane in breast cancer
Published 7 years ago • 869 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
2:49
safety and efficacy of ribociclib and letrozole in advanced breast cancer – the monaleesa-2 trial
-
5:45
real-world: efficacy of everolimus exemestane hr , her2- bc
-
1:41
adapt trial: endocrine ribociclib vs. chemotherapy in hr /her2- early breast cancer
-
1:26
ribecca: ribociclib, a cdk4/6 inhibitor in er breast cancer
-
0:48
maintain: fulvestrant or exemestane /- ribociclib after anti-estrogen therapy cdk4/6i in hr mbc
-
1:40
early ribecca results: ribociclib with letrozole for metastatic breast cancer
-
10:15
monaleesa-3 os results: fulvestrant/ribociclib in postmenopausal hr /her2- advanced breast cancer
-
1:39
frontline endocrine therapies and ribociclib in early stage hr her2- breast cancer
-
0:53
final results of the phase 3 data trial assessing aromatase inhibition in hr breast cancer
-
1:48
natalee and monarche: ribociclib and abemaciclib in hr /her2- breast cancer
-
0:36
maintenance w/ et ribociclib after 1l chemotherapy in hr /her2- metastatic breast cancer
-
7:23
study of ribociclib and pdr001 in hr metastatic breast cancer
-
1:03
azd2014 for treating er metastatic breast cancer – mode of action and trial results
-
1:19
monaleesa-2: improved os seen in hr advanced breast cancer treated with ribociclib letrozole
-
7:14
ribociclib for hr advanced breast cancer
-
1:57
monarcher: final os results of abemaciclib in hr , her breast cancer
-
2:23
natalee: ribociclib nsai as adjuvant treatment in patients with hr /her2− early breast cancer
-
2:46
right choice: ribociclib et vs combo chemo in aggressive hr /her2− advanced breast cancer
-
8:33
bolero-2 trial: everolimus in metastatic breast cancer